The Montreal Clinical Research Institute (IRCM) warmly congratulates its researcher Mathieu Ferron, Director of the IRCM's Molecular Physiology Research Unit, Associate Professor at Université de Montréal and Assistant Professor at McGill University, who has officially received the Prix jeune chercheur André-Dupont 2023 from the Club de Recherches Cliniques du Québec (CRCQ).
Dr. Ferron and his team regularly distinguish themselves in the world of research by their work, which advances knowledge and gives hope of reversing many debilitating pathologies. Most recently, in a salutary advance in our understanding of the mechanisms underlying diabetes, a pathology affecting 1 in 11 people worldwide, his team identified a new role for vitamin K and gamma-carboxylation in beta cells, and their potentially protective role against diabetes.
‘’This new award is a fitting tribute to the long-term, in-depth work of Dr. Ferron and his team, in fields where therapeutic advances can have a positive impact on a very large number of people," enthused Dr. Jean-François Côté, President and Scientific Director of the IRCM.
In 2021, Dr. Ferron had already received the prestigious Fuller Albright Award from the American Society for Bone and Mineral Research (ASBMR) for the excellence of his research work. The Fuller Albright Award is presented to an ASBMR member under the age of 45, in recognition of meritorious scientific achievement in skeletal and bone research. Most recently, he received the Prix reconnaissance Recherche-début de carrière from the Université de Montréal Department of Medicine 2023.
